CORDIS recently published an update about the main goals of the EU-funded Screen4Care project. The project aims to implement genetic newborn screening in Europe to detect a high number of rare diseases. The article highlighted the project’s objective: to leverage genetic testing and AI-assisted data analysis to accelerate the diagnosis and treatment of rare diseases.

The CORDIS article also delves into the project's broader implications, such as its potential for generating valuable research data, promoting more effective treatments, and ensuring equitable access to rare disease diagnosis across EU Member States. The project’s efforts to standardise newborn screening and explore the integration of AI in healthcare systems are crucial steps toward improving the lives of those affected by rare diseases.

For further details and more information about the Screen4Care project, please see the link for Cordis article.